| 貨號 | 規格 | 價格 | 上海 | 北京 | 武漢 | 南京 | 購買數量 |
|---|---|---|---|---|---|---|---|
S88517-1mg |
≥98% | ￥348.00 | 10 | - | - | - |
|
S88517-5mg |
≥98% | ￥1046.00 | 10 | - | - | - |
|
S88517-10mg |
≥98% | ￥1464.00 | 9 | - | - | - |
|
S88517-25mg |
≥98% | ￥2929.00 | 6 | - | - | - |
|
S88517-50mg |
≥98% | ￥4687.00 | 4 | - | - | - |
|
S88517-100mg |
≥98% | ￥7499.00 | 1 | - | - | - |
|
SRI 31215 (TFA) is a Matriptase/Hepsin/hepatocyte growth factor activator (HGFA) triplex inhibitor and mimics the activity of HAI-1/2 (endogenous inhibitors of HGF activation). SRI 31215 has potent inhibitory activity against matriptase, hepsin and HGFA with IC50 values of 0.69 μM, 0.65 μM and 0.30 μM, respectively. SRI 31215 can be used for the research of cancer[1]
| 外觀： | Light yellow to khaki (Solid) |
|---|---|
| 溶解性： | Soluble in DMSO |
| 儲存條件： | -20°C |
| 注意： | 部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網安備 31011702002021號
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京